Nakamoto Y - Search Results

1

Prolonged recurrence-free survival following OK432-stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolization.

Nakamoto Y, Mizukoshi E, Kitahara M, Arihara F, Sakai Y, Kakinoki K, Fujita Y, Marukawa Y, Arai K, Yamashita T, Mukaida N, Matsushima K, Matsui O, Kaneko S. Nakamoto Y, et al. Clin Exp Immunol. 2011 Feb;163(2):165-77. doi: 10.1111/j.1365-2249.2010.04246.x. Epub 2010 Nov 19. Clin Exp Immunol. 2011. PMID: 21087443 Free PMC article.

2

Analysis of intrahepatic lymphocyte subsets in a transgenic mouse model of immune-mediated hepatocarcinogenesis.

Nakamoto Y, Kaneko S. Nakamoto Y, et al. J Exp Clin Cancer Res. 2006 Mar;25(1):55-7. J Exp Clin Cancer Res. 2006. PMID: 16761618

3

Combined therapy of transcatheter hepatic arterial embolization with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety.

Nakamoto Y, Mizukoshi E, Tsuji H, Sakai Y, Kitahara M, Arai K, Yamashita T, Yokoyama K, Mukaida N, Matsushima K, Matsui O, Kaneko S. Nakamoto Y, et al. Clin Exp Immunol. 2007 Feb;147(2):296-305. doi: 10.1111/j.1365-2249.2006.03290.x. Clin Exp Immunol. 2007. PMID: 17223971 Free PMC article.

4

Monocyte-dependent cell death of T lymphocyte subsets in chronic hepatitis C.

Nakamoto Y, Kaneko S, Kobayashi K. Nakamoto Y, et al. Immunol Lett. 2001 Oct 1;78(3):169-74. doi: 10.1016/s0165-2478(01)00257-7. Immunol Lett. 2001. PMID: 11578691

5

Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.

Sakai Y, Kaneko S, Nakamoto Y, Kagaya T, Mukaida N, Kobayashi K. Sakai Y, et al. Among authors: nakamoto y. Cancer Gene Ther. 2001 Oct;8(10):695-704. doi: 10.1038/sj.cgt.7700360. Cancer Gene Ther. 2001. PMID: 11687892

6

Monocyte chemoattractant protein-1 gene delivery enhances antitumor effects of herpes simplex virus thymidine kinase/ganciclovir system in a model of colon cancer.

Kagaya T, Nakamoto Y, Sakai Y, Tsuchiyama T, Yagita H, Mukaida N, Kaneko S. Kagaya T, et al. Among authors: nakamoto y. Cancer Gene Ther. 2006 Apr;13(4):357-66. doi: 10.1038/sj.cgt.7700908. Cancer Gene Ther. 2006. PMID: 16224495

7

Transgenic mice aberrantly expressing pyruvate dehydrogenase complex E2 component on biliary epithelial cells do not show primary biliary cirrhosis.

Inamura K, Tsuji H, Nakamoto Y, Suzuki M, Kaneko S. Inamura K, et al. Among authors: nakamoto y. Clin Exp Immunol. 2006 Jul;145(1):93-100. doi: 10.1111/j.1365-2249.2006.03090.x. Clin Exp Immunol. 2006. PMID: 16792678 Free PMC article.

8

Membrane-bound form of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy in a model of hepatocellular carcinoma.

Marukawa Y, Nakamoto Y, Kakinoki K, Tsuchiyama T, Iida N, Kagaya T, Sakai Y, Naito M, Mukaida N, Kaneko S. Marukawa Y, et al. Among authors: nakamoto y. Cancer Gene Ther. 2012 May;19(5):312-9. doi: 10.1038/cgt.2012.3. Epub 2012 Mar 9. Cancer Gene Ther. 2012. PMID: 22402625 Free article.

9

Inhibition of peripheral blood lymphocyte apoptosis by soluble fas ligand in patients with hepatocellular carcinoma.

Nakamoto Y, Kaneko S, Buttner SW, Matsushita E, Kobayashi K. Nakamoto Y, et al. Oncol Rep. 1999 Jul-Aug;6(4):733-9. doi: 10.3892/or.6.4.733. Oncol Rep. 1999. PMID: 10373647

10

Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver.

Wu Y, Wang YY, Nakamoto Y, Li YY, Baba T, Kaneko S, Fujii C, Mukaida N. Wu Y, et al. Among authors: nakamoto y. Oncogene. 2010 Apr 15;29(15):2228-37. doi: 10.1038/onc.2009.504. Epub 2010 Jan 18. Oncogene. 2010. PMID: 20101231

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

907 results

Search Page

Filters